Masy BioServices Recognized by the Massachusetts Life Science Center
Pepperell, MA, June 24, 2021 – Masy BioServices has received a Tax Incentive award from the Massachusetts Life Sciences Center (MLSC). The Tax Incentive Program celebrates Massachusetts companies certified in the Life Sciences industry. This significant investment by the Commonwealth is designed to expand employment opportunities, promote health-related innovations as well as stimulate research and development, manufacturing and commercialization. Masy is proud to contribute to MLSC’s mission to create jobs in the life sciences and support vital scientific research that will improve the human condition. Masy vows to invest more than $7M to significantly increase high quality product storage services to the pharmaceutical, biotech and medical device industries.
“Masy pledges to increase its Massachusetts based workforce by at least 15% in 2021 to support the increasing demands of its developing business and deliver high quality to our customers. This growth demonstrates our commitment as a critical link in the pharmaceutical and biotechnology supply chain that provides lifesaving drugs to patients and essential services especially in response to COVID,” said Laurie Masiello, President of Masy BioServices. “We are pleased to be recognized by MLSC and look forward to expanding our operations to further life sciences advancements, bolster the economy and contribute to the vitality of our hometown of 12,000 people.”
Masy BioServices has provided quality solutions to the life sciences community for over 35 years and meets rigorous qualifications from NVLAP accreditation to ISO 17025:2017 as well as ISO 9001:2015 certification. Services include calibration of primary standards and critical test equipment; validation and IQ/OQ/PQ of environmental chambers, autoclaves, and thermal warehouse mapping; and equipment rentals and sales. Masy has a premier cGMP biorepository, offering secure and tightly controlled temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds, and medical devices.
Press Contact:
Kristine LeBlanc
Senior Marketing Manager
Masy BioServices
978-433-6279 x 1458